Aptamer 学术简报 — therapeutic — 2026-06-08

自动生成 by RBTX Aptamer Tracker v0.1。 子主题 therapeutic：近 14 天 69 篇命中（aptamer 池 236 篇）。

评分公式：composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus；满分 100。

#1 [17.7] Circular RNA-mediated regulation of key signaling pathways in cardiovascular diseases: a review.

Cardiovascular diseases (CVDs) are globally prevalent pathologies driven by dysregulated signaling networks. Circular RNAs (circRNAs), a class of covalently closed non-coding RNAs produced by back-splicingmechanism, in which a downstream 5' splice site joins an upstream 3' splice site, have emerged as critical regulators of CVD pathogenesis. Thi...

#2 [14.0] Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.

BACKGROUND: Joint use of multiple molecular layers can be useful to prioritize targets for mechanistic studies. Application of this approach to coronary disease in large populations is an emerging field. METHODS: We used reported circulating proteomic data (Somascan aptamer-based) from ≈3000 individuals in the CARDIA study (Coronary Artery Risk ...

#3 [13.8] Tracing Tumor-Derived Extracellular Vesicle Matrix Metalloproteinase 14 Using Dual-Target Orthogonal Barcoding-Based Microscale Thermophoretic Assays.

Longitudinal monitoring of tumor progression and metastasis provides significant benefits to improve the treatment outcome of breast cancer. Matrix metalloproteinase 14 (MMP14) on extracellular vesicles (EVs) is highly relevant to tumor invasiveness, yet the sensitivity and specificity of detection are hindered by tremendous amounts of normal EV...

#4 [13.5] Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.

Aptamers are a versatile alternative to antibodies as they are smaller, easier to synthesize and less immunogenic. However, while antibodies are composed of 20 chemically diverse amino acids and are established therapeutics, aptamers are composed of only 4 similar nucleobases, thereby limiting their therapeutic potential. Aptamer chemical modifi...

#5 [13.3] A Proximity-Induced pH-Responsive DNA Switch for Reversible Capture and Release of Extracellular Vesicles.

Extracellular vesicles (EV) serve as critical mediators in physiological and pathological processes, holding great promise for cancer diagnosis, real-time monitoring, and prognostic applications. However, their small size and low density present considerable challenges in achieving efficient, specific, and mild isolation, which currently hinders...

#6 [13.1] A label-free electrochemical aptasensor enables ultrasensitive and specific detection of neurofilament light.

Plasma neurofilament light chain (NfL) has been identified as a promising early-stage Alzheimer's disease (AD) biomarker, reflecting neuroaxonal degeneration at preclinical stages. However, its extremely low concentration in blood presents a major analytical challenge. Although single-molecule array (Simoa) assays provide exceptional sensitivity...

#7 [12.9] CRISPR/Cas12a-driven miRNA-hypersensitive intelligent nanodrug release system for precision therapy of resistant triple-negative breast cancer

#8 [12.8] Dynamic Switchable and Transient DNA Condensates Driven by Aptamer-Ligand or Ion-Nucleobase Bridged Complexes.

Phase-separated DNA-based coacervates undergoing dynamic switchable or transient evolution and depletion are introduced. Y-shaped DNA reaction modules crosslinked by palindromic strands conjugated to cooperatively stabilized metal-ions/mismatched bridges, C-Ag+-C or T-Hg2+-T, evolved phase-separated microdroplets. Removal of the bridging ions by...

#9 [12.5] Bispecific aptamer LYTAC for PCSK9 degradation: a promising strategy for cholesterol regulation.

PCSK9 is a key regulator of LDLR turnover and an established therapeutic target for CVD. Here, we report the development of a bispecific DNA aptamer-based lysosome-targeting chimera (PCSK9-LYTAC) that promotes extracellular degradation of PCSK9 via IGFIIR-mediated lysosomal trafficking. This dual-aptamer construct simultaneously blocks the PCSK9...

#10 [12.3] Assembled DNA Nanostructure to Precisely Induced cGAS-STING Activation for Cancer Immunotherapy.

Triple-negative breast cancer (TNBC) has emerged as a major challenge in cancer therapy due to its aggressive nature and lack of effective targeted treatments. Activating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway to stimulate innate immunity is considered a promising strategy for TNBC treatment. However, cur...

Methodology